PULPAC has confirmed Papela’s participation in the Blister Pack Collective, a cross-industry initiative created by PA Consulting and PulPac to advance dry moulded fibre blister packaging.
Papela will act as the Collective’s first converter partner and contribute expertise on the development of packaging for nutraceuticals, supplements, and healthcare-related products.
Blister packs remain one of the most widely used formats for tablets and capsules, often relying on plastic or other materials that are difficult to recycle. The Blister Pack Collective brings together partners across the value chain to accelerate the development of fibre-based alternatives that can reduce plastic use while supporting the performance, protection, and scalability required for commercial adoption.
Papela strengthens a Collective that already includes companies such as Haleon, Opella, Bayer Consumer Health and Sanofi Rx.
“For many brands, the challenge is not only finding a more sustainable blister format, but making the transition practical. Through the Blister Pack Collective, we are working with PA and PulPac to help bring fibre-based blister packaging closer to market,” said Sander Volden, founder and CEO of Papela.
Dry moulded fibre is PulPac’s patented technology for turning renewable fibres into ‘high-performance’ packaging through a dry forming process. For blister applications, the technology is described as opening opportunities to reduce plastic content while supporting the detailed forming, barrier integration, consumer desirability, and production scalability required for tablet and capsule packaging.
